Citizen Petition from Pharmaceutical Safety Oversight Council
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Pharmaceutical Safety Oversight Council
- Posted
- Jun 3, 2026
- Comment period
- Jun 3, 2026 – ?
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 28, 2026Comment from Nelson, Mary ThereseSupportIndividualRead comment →
- Jul 28, 2026Comment from Nelson, Mary ThereseSupportIndividualRead comment →
- Jul 28, 2026Comment from Lee, CorinneSupportIndividual
A pet owner is submitting a comment in support of the citizen petition to remove Solensia from the market. They argue that the drug caused severe side effects and death in their cat and claim that veterinarians are under-reporting these adverse events.
Read comment → - Jul 28, 2026Comment from Gotto RhondaAnalysis pending📎 AttachmentRead comment →
- Jul 27, 2026Comment from Bridges KaylaAnalysis pending📎 AttachmentRead comment →
- Jul 26, 2026Comment from Bollmann CarrieSupportIndividualRead comment →
- Jul 25, 2026Comment from Stith Burdette SarahAnalysis pending📎 AttachmentRead comment →
- Jul 25, 2026Comment from Plummer ChrisSupportIndividual
The commenter is a pet owner who shares a personal story about their dog's severe adverse reactions to the drug Librela. They are urging the agency to remove the product from the market or issue a warning to veterinarians and owners.
Read comment → - Jul 25, 2026Comment from Shirley TiffanyAnalysis pending📎 AttachmentRead comment →
- Jul 24, 2026Comment from Mciver LouisaSupportIndividual
An individual is sharing a personal anecdote about their dog suffering a severe adverse reaction (seizures) after receiving a Librela injection. By providing this testimony in response to a petition regarding pharmaceutical safety oversight, the commenter supports the action of increased oversight.
Read comment →